Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only...
FDA Drug Recall #D-1616-2014 — Class II — April 24, 2014
Recall Summary
| Recall Number | D-1616-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 24, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Actavis Laboratories, FL, Inc. |
| Location | Davie, FL |
| Product Type | Drugs |
| Quantity | 36,538 bottles |
Product Description
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.
Reason for Recall
Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
Distribution Pattern
Nationwide and Puerto Rico
Lot / Code Information
Lot #: 605956A, 605958A, Exp. 9/30/2014; 644678M, Exp. 10/31/2014; 661841A, Exp. 11/30/2014; 717469A, Exp 2/28/2015
Other Recalls from Actavis Laboratories, FL, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0118-2017 | Class III | Ramipril Capsules, USP, 1.25 mg, 30-count bottl... | Aug 30, 2016 |
| D-0014-2016 | Class II | Metformin Hydrochloride Extended-Release Tablet... | Sep 25, 2015 |
| D-1285-2015 | Class III | Desmopressin Acetate Tablets, 0.1mg, 100 Count ... | Jun 23, 2015 |
| D-0488-2015 | Class III | Cartia XT (diltiazem HCl extended-release capsu... | Mar 26, 2015 |
| D-0258-2015 | Class II | Diclofenac Sodium and Misoprostol Delayed-Relea... | Sep 26, 2014 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.